• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALCON RESEARCH, LTD. - HUNTINGTON ACRYSOF IQ SINGLEPIECE IOL W/ULTRASERT DELIVERY SYSTEM; LENS, GUIDE, INTRAOCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALCON RESEARCH, LTD. - HUNTINGTON ACRYSOF IQ SINGLEPIECE IOL W/ULTRASERT DELIVERY SYSTEM; LENS, GUIDE, INTRAOCULAR Back to Search Results
Model Number AU00T0
Device Problems Break (1069); Scratched Material (3020)
Patient Problem No Code Available (3191)
Event Date 10/22/2015
Event Type  Injury  
Manufacturer Narrative
Evaluation summary: product history and batch records were reviewed and documentation indicated the product met release criteria.Root cause has not been identified.Additional information has been requested but not received to date.
 
Event Description
A doctor of ophthalmology reported that during an intraocular lens (iol) implant surgery, the plunger damaged the optical part of the lens making a large scratch on the optic.The cartridge was filled from the tip up to the mark with viscoelastic as required, lens was pushed forward properly and in compliance with the time intervals and implanted.Lens had to be removed and substituted for a different one that was implanted manually.Incision had to be sealed at the end of the surgery with a single corneal suture.Additional information has been requested but not received to date.
 
Manufacturer Narrative
Evaluation summary: the root cause may be related to a failure to follow the directions for use (dfu).As stated in the intraocular lens with the preloaded delivery system involved dfu, only two qualified viscoelastics must be used in conjunction with the device.All other viscoelastics, including the one reported by customer, are not qualified for use.Lens delivery performance may be negatively affected when using a non-qualified viscoelastic leading to lens delivery issues and /or damage.The use of non-qualified viscoelastics is considered a failure to follow the dfu for the intraocular lens with preloaded delivery system used and is not recommended under any circumstance.
 
Manufacturer Narrative
(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACRYSOF IQ SINGLEPIECE IOL W/ULTRASERT DELIVERY SYSTEM
Type of Device
LENS, GUIDE, INTRAOCULAR
Manufacturer (Section D)
ALCON RESEARCH, LTD. - HUNTINGTON
6065 kyle lane
huntington WV 25702
Manufacturer (Section G)
ALCON RESEARCH, LTD. - HUNTINGTON
6065 kyle lane
huntington WV 25702
Manufacturer Contact
eddie darton, md, jd
6201 south freeway
mail stop ab2-6
fort worth, TX 76134
8175686660
MDR Report Key5229325
MDR Text Key31360047
Report Number1119421-2015-06604
Device Sequence Number1
Product Code KYB
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
P930014
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Health Professional
Remedial Action Other
Type of Report Initial,Followup,Followup,Followup
Report Date 03/15/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/17/2015
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/31/2017
Device Model NumberAU00T0
Device Catalogue NumberAU00T0.220
Device Lot Number12387051
Other Device ID Number00380652358316
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/15/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/03/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
Patient Age71 YR
-
-